Patexia Research

Case number 1:19-cv-01975

Lawsuits

sanofi-aventis U.S. LLC et al v. Shilpa Medicare Limited > Summary

Court Case Number 1:19-cv-01975

Filing Date Oct 17, 2019

Termination Date May 13, 2020

Court Delaware District Court

Status Dismissed - Voluntarily

JudgesMaryellen Noreika

Plaintiff

2

Defendant

Shilpa Medicare Limited

Plaintiff Attorneys

28

Sanofi
Attorney Name: Jeffrey B. Bove
Buchanan Ingersoll & Rooney PC

Sanofi
Attorney Name: Karen Riesenburger Poppel
Buchanan Ingersoll & Rooney PC

Aventisub LLC
Attorney Name: Jeffrey B. Bove
Buchanan Ingersoll & Rooney PC

Aventisub LLC
Attorney Name: Karen Riesenburger Poppel
Buchanan Ingersoll & Rooney PC

SANOFI-AVENTIS DEUTSCHLAND GMBH
Attorney Name: Paul H. Berghoff
McDonnell Boehnen Hulbert & Berghoff LLP

SANOFI-AVENTIS DEUTSCHLAND GMBH
Attorney Name: Alison J. Baldwin
McDonnell Boehnen Hulbert & Berghoff LLP

SANOFI-AVENTIS DEUTSCHLAND GMBH
Attorney Name: James L. Lovsin
McDonnell Boehnen Hulbert & Berghoff LLP

SANOFI-AVENTIS DEUTSCHLAND GMBH
Attorney Name: John E. Conour
McDonnell Boehnen Hulbert & Berghoff LLP

SANOFI-AVENTIS DEUTSCHLAND GMBH
Attorney Name: Nathaniel P. Chongsiriwatana
McDonnell Boehnen Hulbert & Berghoff LLP

SANOFI-AVENTIS DEUTSCHLAND GMBH
Attorney Name: Daniel F. Gelwicks
McDonnell Boehnen Hulbert & Berghoff LLP

Aventisub LLC
Attorney Name: Paul H. Berghoff
McDonnell Boehnen Hulbert & Berghoff LLP

Sanofi
Attorney Name: Paul H. Berghoff
McDonnell Boehnen Hulbert & Berghoff LLP

Sanofi Genzyme
Attorney Name: Paul H. Berghoff
McDonnell Boehnen Hulbert & Berghoff LLP

Aventisub LLC
Attorney Name: Alison J. Baldwin
McDonnell Boehnen Hulbert & Berghoff LLP

Sanofi
Attorney Name: Alison J. Baldwin
McDonnell Boehnen Hulbert & Berghoff LLP

Sanofi Genzyme
Attorney Name: Alison J. Baldwin
McDonnell Boehnen Hulbert & Berghoff LLP

Aventisub LLC
Attorney Name: James L. Lovsin
McDonnell Boehnen Hulbert & Berghoff LLP

Sanofi
Attorney Name: James L. Lovsin
McDonnell Boehnen Hulbert & Berghoff LLP

Sanofi Genzyme
Attorney Name: James L. Lovsin
McDonnell Boehnen Hulbert & Berghoff LLP

Aventisub LLC
Attorney Name: John E. Conour
McDonnell Boehnen Hulbert & Berghoff LLP

Sanofi
Attorney Name: John E. Conour
McDonnell Boehnen Hulbert & Berghoff LLP

Sanofi Genzyme
Attorney Name: John E. Conour
McDonnell Boehnen Hulbert & Berghoff LLP

Aventisub LLC
Attorney Name: Nathaniel P. Chongsiriwatana
McDonnell Boehnen Hulbert & Berghoff LLP

Sanofi
Attorney Name: Nathaniel P. Chongsiriwatana
McDonnell Boehnen Hulbert & Berghoff LLP

Sanofi Genzyme
Attorney Name: Nathaniel P. Chongsiriwatana
McDonnell Boehnen Hulbert & Berghoff LLP

Aventisub LLC
Attorney Name: Daniel F. Gelwicks
McDonnell Boehnen Hulbert & Berghoff LLP

Sanofi
Attorney Name: Daniel F. Gelwicks
McDonnell Boehnen Hulbert & Berghoff LLP

Sanofi Genzyme
Attorney Name: Daniel F. Gelwicks
McDonnell Boehnen Hulbert & Berghoff LLP

Defendant Attorneys

Shilpa Medicare Limited
Attorney Name: Kate Harmon
Benesch

Cause

35:271 Patent Infringement

Related Patents

Doc No	Title	Issue date
09186346	Methods for reducing the risk of an adverse teriflunomide and rosuvastatin interaction in multiple sclerosis patients	Nov 17, 2015
06794410	Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4-trifluoromethylphenyl)-amide for treating multiple sclerosis	Sep 21, 2004